ACER Acer Therapeutics Inc.

Acer Therapeutics Inc is a pharmaceutical company that acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need.

$1.35  +0.08 (6.30%)
As of 12/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  15,942,749
Average volume:  103,643
Market cap:   $20,247,291
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -3.41
PB ratio:   8.41
PS ratio:   4.24
Return on equity:   123.09%
Net income %:   -285.31%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy